Kinetic analysis and optimisation of (18)F-rhPSMA-7.3 PET imaging of prostate cancer

PURPOSE: This phase 1 open-label study evaluated the uptake kinetics of a novel theranostic PET radiopharmaceutical, (18)F-rhPSMA-7.3, to optimise its use for imaging of prostate cancer. METHODS: Nine men, three with high-risk localised prostate cancer, three with treatment-naïve hormone-sensitive m...

Descripción completa

Detalles Bibliográficos
Autores principales: Malaspina, Simona, Oikonen, Vesa, Kuisma, Anna, Ettala, Otto, Mattila, Kalle, Boström, Peter J., Minn, Heikki, Kalliokoski, Kari, Postema, Ernst J., Miller, Matthew P., Scheinin, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440272/
https://www.ncbi.nlm.nih.gov/pubmed/33846844
http://dx.doi.org/10.1007/s00259-021-05346-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440272/
https://www.ncbi.nlm.nih.gov/pubmed/33846844
http://dx.doi.org/10.1007/s00259-021-05346-8

Ejemplares similares